Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial
Borel, Christian, Sun, Xu-Shan, Coutte, Alexandre, Bera, Guillaume, Sire, Christian, Zanetta, Sylvie, Alfonsi, Marc, Janoray, Guillaume, Chatellier, Thierry, Garcia-Ramirez, Muriel, Gherga, Elisabeta, Hammoud, Yasser, Burgy, Mickaël, Etienne-Selloum, Nelly, Pechery, Adeline, Girard-Calais, Marie-Hélène, Velten, Michel, Pignon, Jean-Pierre, Wanneveich, Mathilde, Bourhis, Jean
Published in Radiotherapy and oncology (01.08.2024)
Published in Radiotherapy and oncology (01.08.2024)
Get full text
Journal Article
Impact of p16 expression on induction taxotere-cisplatin-5 FU (TPF) followed by cetuximab-radiotherapy in N2b-N3 head and neck squamous cell carcinoma (HNSCC): Results of GORTEC 2007-02 phase III randomized trial
Tao, Yungan, Geoffrois, Lionnel, Martin, Laurent, De Raucourt, Dominique, Miny, Joelle, Maingon, Philippe, Lafond, Cedrik, Tuchais, Claude, Sire, Christian, Babin, Emmanuel, Coutte, Alexandre, Rolland, Frederic, Girard-Calais, Marie-Helene, Casiraghi, Odile, Garaud, Pascal, Bourhis, Jean
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Induction docetaxel platinum 5-FU (TPF) followed by cetuximab-radiotherapy (cetux-RT) versus concurrent chemo-radiotherapy (CT/RT) in patients with N2b/c-N3 non operated stage III-IV squamous cell cancer of the head and neck (SCCHN): Results of the GORTEC 2007-02 phase III randomized trial
Geoffrois, Lionnel, Martin, Laurent, Garaud, Pascal, De Raucourt, Dominique, Miny, Joelle, Maingon, Philippe, Lafond, Cedrik, Tuchais, Claude, Sire, Christian, Babin, Emmanuel, Coutte, Alexandre, Tao, Yungan, Rolland, Frederic, Girard-Calais, Marie Helene, Bourhis, Jean
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article